Preemptive azacitidine treatment guided by measurable residual disease (MRD) status was associated with delayed relapse in patients with myelodysplastic neoplasms or acute myeloid leukemia (AML), with ...
A decade or so ago, reading instruction underwent a public reassessment. Whole language approaches had emphasized immersion in texts and contextual, “cue"-based guessing strategies. The goals were ...
Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform Pathlight, developer Saga Diagnostics entered a definitive merger agreement ...
Police spent the early hours of Friday morning investigating a report of a shooting in Baltimore's Ellwood Park neighborhood. Police seek leads as community voices fear, anger after deadly Columbia ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new publication validating the company’s NeXT Personal test, ...